Type 2 Diabetes Mellitus Treatment Companies
Companies involved in the treatment of Type 2 Diabetes Mellitus (T2DM) cover a broad spectrum, including pharmaceuticals, medical devices, and healthcare services.
Companies involved in the treatment of Type 2 Diabetes Mellitus (T2DM) cover a broad spectrum, including pharmaceuticals, medical devices, and healthcare services.
Eli Lilly Announced positive Phase 3 trial results for its GLP-1 receptor agonist Tirzepatide, demonstrating superior blood sugar control and weight loss compared to existing drugs.
Novo Nordisk Received FDA approval for its dual SGLT2/GLP-1 agonist Ozempic®, offering a new option for patients with inadequate glycemic control on other medications.
Boehringer Ingelheim Partnered with Eli Lilly to co-develop and commercialize their next-generation SGLT2 inhibitor Jardiance®, aiming to expand their reach in the diabetes market.
List of Type 2 Diabetes Mellitus Treatment Key Companies in the Market
Type 2 Diabetes Mellitus Treatment Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)